CPG
AMRX icon

Cornerstone Planning Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Cornerstone Planning Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$710 Hold
40
– – ﹤0.01% 1590
2026
Q1 		$537 Hold
40
– – ﹤0.01% 1626
2025
Q4 		$558 Hold
40
– – ﹤0.01% 1490
2025
Q3 		$400 Hold
40
– – ﹤0.01% 1529
2025
Q2 		$325 Hold
40
– – ﹤0.01% 1403
2025
Q1 		$292 Hold
40
– – ﹤0.01% 1421
2024
Q4 		$353 Buy
+40
New +$336 ﹤0.01% 1239

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WW
Westshore Wealth Newport Beach, California $322M AUM 24.46% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Cornerstone Planning Group's AMRX Position: Q2 2026 in Review

Cornerstone Planning Group held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 40 shares worth $710. The position accounts for ﹤0.01% of the portfolio, ranked #1590.

Cornerstone Planning Group first reported a position in AMRX in Q4 2024 and has held it in 7 quarters since. 134 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Cornerstone Planning Group held 40 shares of Amneal Pharmaceuticals worth $710 as of Q2 2026.
  • Cornerstone Planning Group left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #1590 holding.
  • Cornerstone Planning Group first reported a position in Amneal Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 134 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.